Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

PharmAust Limited (AU: PAA)

 
PAA Technical Analysis
4
As on 16th Dec 2024 PAA STOCK Price closed @ 0.16 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.16 & Strong Buy for SHORT-TERM with Stoploss of 0.08 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

PAASTOCK Price

Open 0.17 Change Price %
High 0.18 1 Day -0.02 -11.11
Low 0.16 1 Week -0.02 -11.11
Close 0.16 1 Month -0.04 -20.00
Volume 882169 1 Year 0.08 100.00
52 Week High 0.42 | 52 Week Low 0.07
 
AU Australia Most Active Stocks
WHK 0.03 200.00%
BTR 0.02 0.00%
CRS 0.06 -33.33%
JAY 0.00 %
ATH 0.01 0.00%
PLS 1.59 -5.36%
TLS 4.27 1.43%
PNR 0.16 -5.88%
CLA 0.01 %
OZM 0.09 50.00%
 
AU Australia Top Gainers Stocks
IXU 0.18 1700.00%
WHK 0.03 200.00%
APV 0.02 100.00%
FG1 0.03 50.00%
FG1 0.03 50.00%
FG1 0.03 50.00%
FG1 0.03 50.00%
FG1 0.03 50.00%
INF 0.03 50.00%
INF 0.03 50.00%
 
AU Australia Top Losers Stocks
RDN 0.00 -100.00%
RDN 0.00 -100.00%
RDN 0.00 -100.00%
RDN 0.00 -100.00%
ROG 0.00 -100.00%
ROG 0.00 -100.00%
ROG 0.00 -100.00%
ROG 0.00 -100.00%
ROG 0.00 -100.00%
AX8 0.00 -100.00%
 
 
PAA
Daily Charts		 PAA
Intraday Charts		 Whats New @
Bazaartrend		 PAA
Free Analysis
 
PAA Important Levels Intraday
RESISTANCE0.20
RESISTANCE0.19
RESISTANCE0.18
RESISTANCE0.17
SUPPORT0.15
SUPPORT0.14
SUPPORT0.13
SUPPORT0.12
 
PAA Forecast April 2025
Share
4th UP Forecast0.22
3rd UP Forecast0.2
2nd UP Forecast0.19
1st UP Forecast0.18
1st DOWN Forecast0.14
2nd DOWN Forecast0.13
3rd DOWN Forecast0.12
4th DOWN Forecast0.1
 
PAA Weekly Forecast
4th UP Forecast0.16
3rd UP Forecast0.16
2nd UP Forecast0.16
1st UP Forecast0.16
1st DOWN Forecast0.16
2nd DOWN Forecast0.16
3rd DOWN Forecast0.16
4th DOWN Forecast0.16
 
PAA Forecast2025
4th UP Forecast1.07
3rd UP Forecast0.78
2nd UP Forecast0.6
1st UP Forecast0.42
1st DOWN Forecast-0.1
2nd DOWN Forecast-0.28
3rd DOWN Forecast-0.46
4th DOWN Forecast-0.75
 
 
PAA Other Details
Segment EQ
Market Capital 31057376.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
PAA Address
PAA
 
PAA Latest News
 
Your Comments and Response on PharmAust Limited
 
PAA Business Profile
PharmAust Limited, a clinical-stage company, develops targeted cancer therapeutics for humans and animals. The company develops drugs for the treatment of various cancers, and viral and neurological diseases. Its lead candidate is Monepantel (MPL), a small molecule drug for the treatment of cancer. PharmAust has completed Phase 1 clinical trials with monepantel in human and dog diagnosed with solid tumors, as well as initiated a Phase 2 pilot study in dogs diagnosed with Lymphoma. The company also provides products and services in synthetic and medicinal chemistry to the drug discovery and pharmaceutical industries worldwide. The company has a research agreement with the Walter and Eliza Hall Institute to investigate the effects of MPL upon human T-lymphotrophic virus-1 (HTLV-1) infections in vitro. It serves drug discovery and pharmaceutical industries. PharmAust Limited was incorporated in 2000 and is based in Bentley, Australia. Address: 5/3 Brodie Hall Drive, Bentley, WA, Australia, 6102
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service